Trial Profile
A Randomized, Double-blind Study Evaluating the Upper Gastrointestinal Safety on Multiple Doses of CG100649 in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Jan 2022
Price :
$35
*
At a glance
- Drugs Polmacoxib (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions
- 30 Dec 2021 Results of population pharmacokinetic and pharmacodynamic models of polmacoxib, in both healthy volunteers and patients with Osteoarthritis published in the Clinical Therapeutics
- 27 Jan 2016 Study design has been changed from single group assignment to parallel group assignment according to ClinicalTrials.gov.
- 19 Nov 2015 Status changed from active, no longer recruiting to completed.